Tokushima, Japan

Muneaki Kurimura

USPTO Granted Patents = 17 


 

Average Co-Inventor Count = 11.3

ph-index = 4

Forward Citations = 77(Granted Patents)


Location History:

  • Rockville, MD (US) (2008 - 2010)
  • Naruto, JP (2000 - 2013)
  • Osaka, JP (2015 - 2017)
  • Tokushima, JP (2003 - 2018)

Company Filing History:


Years Active: 2000-2018

Loading Chart...
Loading Chart...
Loading Chart...
17 patents (USPTO):

Title: An Insight into the Innovations of Muneaki Kurimura

Introduction: Muneaki Kurimura, an accomplished inventor based in Tokushima, Japan, has made significant contributions to the field of pharmaceutical chemistry. Holding a total of 17 patents, he has focused on developing innovative compounds that target various health disorders, particularly those related to neurological functions.

Latest Patents: Among Kurimura's recent innovations is a patent for N,N-substituted 3-aminopyrrolidine compounds. These compounds serve as monoamines reuptake inhibitors, with the potential for creating pharmaceutical preparations that offer a wider therapeutic spectrum. The patent describes a pyrrolidine compound of General Formula (1), which can be utilized to exhibit sufficient therapeutic effects even after short-term administration. Furthermore, he has worked on therapeutic compounds and related methods that aim to treat disorders by modulating striatal-enriched tyrosine phosphatase (STEP). These methods focus on conditions such as schizophrenia and cognitive deficits, enhancing the therapeutic landscape for these challenging health issues.

Career Highlights: Muneaki Kurimura has developed a robust career at Otsuka Pharmaceutical Company, Limited, where he continues to drive innovation in pharmaceutical applications. His extensive patent portfolio reflects his expertise and dedication to research and development in the medical field.

Collaborations: Throughout his career, Kurimura has collaborated with notable colleagues such as Takayuki Matsuzaki and Tomoichi Shinohara. These collaborations have helped foster a dynamic environment for research and have contributed to the advancement of novel therapeutic approaches.

Conclusion: Muneaki Kurimura exemplifies the spirit of innovation within the pharmaceutical industry. His work not only addresses pressing health challenges but also showcases the potential of scientific research to create impactful solutions. As he continues his endeavors at Otsuka Pharmaceutical Company, his contributions will undoubtedly pave the way for future advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…